Molecular Partners AG

3.81
-0.03 (-0.78%)
At close: Apr 02, 2025, 3:44 PM
3.81
0.00%
After-hours: Apr 02, 2025, 04:00 PM EDT

Molecular Partners AG Statistics

Share Statistics

Molecular Partners AG has 36.87M shares outstanding. The number of shares has increased by 11.13% in one year.

Shares Outstanding 36.87M
Shares Change (YoY) 11.13%
Shares Change (QoQ) 0.03%
Owned by Institutions (%) 10.79%
Shares Floating 36.77M
Failed to Deliver (FTD) Shares 22
FTD / Avg. Volume 0.59%

Short Selling Information

The latest short interest is 44.78K, so 0.12% of the outstanding shares have been sold short.

Short Interest 44.78K
Short % of Shares Out 0.12%
Short % of Float 0.12%
Short Ratio (days to cover) 5.49

Valuation Ratios

The PE ratio is -2.65 and the forward PE ratio is -3.24. Molecular Partners AG's PEG ratio is 0.19.

PE Ratio -2.65
Forward PE -3.24
PS Ratio 28.8
Forward PS 1.2
PB Ratio 1.01
P/FCF Ratio -2.39
PEG Ratio 0.19
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Molecular Partners AG.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 14.31, with a Debt / Equity ratio of 0.02.

Current Ratio 14.31
Quick Ratio 14.31
Debt / Equity 0.02
Debt / EBITDA -0.05
Debt / FCF -0.04
Interest Coverage -2448.68

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $31.46K
Profits Per Employee $-342.04K
Employee Count 158
Asset Turnover 0.03
Inventory Turnover n/a

Taxes

Income Tax 2K
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by 1.79% in the last 52 weeks. The beta is 0.63, so Molecular Partners AG's price volatility has been higher than the market average.

Beta 0.63
52-Week Price Change 1.79%
50-Day Moving Average 4.74
200-Day Moving Average 5.6
Relative Strength Index (RSI) 38.68
Average Volume (20 Days) 3.71K

Income Statement

In the last 12 months, Molecular Partners AG had revenue of 4.97M and earned -54.04M in profits. Earnings per share was -1.63.

Revenue 4.97M
Gross Profit 4.97M
Operating Income -61.22M
Net Income -54.04M
EBITDA -51.65M
EBIT -54.02M
Earnings Per Share (EPS) -1.63
Full Income Statement

Balance Sheet

The company has 63.87M in cash and 2.44M in debt, giving a net cash position of 61.43M.

Cash & Cash Equivalents 63.87M
Total Debt 2.44M
Net Cash 61.43M
Retained Earnings -246.29M
Total Assets 158.53M
Working Capital 143.5M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -59.25M and capital expenditures -723K, giving a free cash flow of -59.97M.

Operating Cash Flow -59.25M
Capital Expenditures -723K
Free Cash Flow -59.97M
FCF Per Share -1.81
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -1231.73% and -1087.38%.

Gross Margin 100%
Operating Margin -1231.73%
Pretax Margin -1087.34%
Profit Margin -1087.38%
EBITDA Margin -1039.18%
EBIT Margin -1231.73%
FCF Margin -1206.66%

Dividends & Yields

MOLN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for MOLN.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Scores

Altman Z-Score 2.81
Piotroski F-Score 2